GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Human Metabolome Technologies 6090.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

565

+0.89%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥1.42bn

FY2017FY2026

Net income

¥200.4m

FY2017FY2026

Free cash flow

¥148.5m

FY2017FY2026

Shareholders' equity

¥1.83bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥1.42bn¥1.46bn¥1.35bn¥1.30bn¥1.22bn¥1.12bn¥1.12bn¥834.1m¥938.2m¥914.2m
Gross profit¥868.5m¥922.0m¥869.3m¥859.8m¥840.0m¥806.0m¥856.7m¥578.1m¥742.5m¥729.1m
Research and development——¥146.0m¥185.0m¥158.0m¥98.0m¥155.0m¥189.0m¥235.0m¥209.0m
Operating income¥209.9m¥250.4m¥222.2m¥213.2m¥193.4m¥40.8m−¥24.2m−¥365.3m−¥140.9m−¥43.3m
Net income¥200.4m¥256.0m¥243.2m¥285.8m¥267.8m¥58.2m−¥47.8m−¥360.0m−¥156.5m−¥61.9m
Diluted earnings per share36.7245.4941.1048.3245.389.87-8.11-61.42-26.77-10.59

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥2.28bn¥2.37bn¥2.60bn¥2.29bn¥2.07bn¥1.62bn¥1.54bn¥1.37bn¥1.92bn¥2.02bn
Cash and short-term investments¥1.44bn¥1.59bn¥1.79bn¥1.66bn¥1.50bn¥1.25bn¥1.22bn¥1.05bn¥1.46bn¥1.62bn
Total liabilities¥451.4m¥466.1m¥656.8m¥518.9m¥583.4m¥363.3m¥322.9m¥153.0m¥168.6m¥162.6m
Debt¥103.0m¥110.5m¥226.3m¥226.5m¥233.2m¥152.7m¥19.7m¥29.4m¥41.2m¥2.7m
Shareholders' equity¥1.83bn¥1.91bn¥1.95bn¥1.77bn¥1.49bn¥1.26bn¥1.22bn¥1.21bn¥1.75bn¥1.86bn
Shares outstanding5m6m6m6m6m6m6m6m6m6m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥208.6m¥373.0m¥236.8m¥285.0m¥324.0m−¥34.2m¥184.1m−¥212.0m−¥178.0m¥45.2m
Capital spending−¥60.1m−¥148.0m−¥34.1m−¥116.9m−¥146.1m−¥27.9m−¥34.8m−¥113.6m−¥85.0m−¥35.0m
Free cash flow¥148.5m¥225.0m¥202.7m¥168.1m¥177.9m−¥62.0m¥149.2m−¥325.6m−¥263.0m¥10.2m
Dividends paid−¥85.0m−¥88.0m−¥58.7m———————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥314.8m¥448.0m¥466.8m¥192.4m¥189.0m¥581.9m¥410.0m¥274.0m
Gross profit¥168.8m¥318.2m¥305.2m¥76.3m¥75.0m¥408.5m¥283.9m¥154.0m
Operating income¥1.2m¥161.8m¥138.0m−¥91.1m−¥104.0m¥249.4m¥109.0m−¥5.0m
Net income¥34.6m¥121.9m¥141.0m−¥97.2m−¥48.0m¥211.2m¥128.0m−¥35.0m
Diluted earnings per share6.3522.3325.06-17.27-8.5337.5221.63-5.91
Total assets¥2.28bn¥2.29bn¥2.14bn¥2.00bn¥2.37bn¥2.67bn¥2.45bn¥2.29bn
Cash and short-term investments¥1.44bn¥1.46bn¥1.21bn¥1.29bn¥1.59bn¥1.64bn¥1.60bn¥1.46bn
Debt¥103.9m¥101.2m¥102.4m¥104.3m¥107.0m¥206.0m¥210.2m¥212.0m
Shareholders' equity¥1.83bn¥1.88bn¥1.81bn¥1.69bn¥1.91bn¥2.07bn¥1.93bn¥1.81bn

Financial ratios

Data as of 18 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin61.1%63.4%64.6%66.2%68.7%71.7%——
Operating margin14.8%17.2%19.6%18.4%21.6%4.7%——
Net margin14.1%17.6%18.1%22.0%21.9%5.2%——
Return on equity11.0%13.4%12.5%16.1%18.0%4.6%——
Return on assets8.8%10.8%9.3%12.5%12.9%3.6%——
Free cash flow yield6.3%11.0%6.6%8.0%9.1%-1.0%——
Revenue growth-2.3%8.1%3.6%6.2%8.8%0.5%——
Earnings growth-21.7%5.2%-14.9%6.7%360.0%-221.8%——
Current ratio4.03x4.14x3.31x3.75x3.19x4.59x——
Debt to equity0.06x0.06x0.11x0.12x0.14x0.09x——
Equity ratio80.2%80.4%74.8%77.4%71.8%77.6%——
Interest coverage105.86x100.28x126.01x105.64x119.30x34.13x——
R&D as a share of sales——10.8%14.2%12.9%8.7%13.9%22.5%
Buybacks as a share of market value3.0%4.9%-0.1%-0.2%-0.0%-0.1%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.1%4.8%6.2%
Operating income-0.5%38.8%—
Net income-11.2%28.0%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin62.2%63.7%65.6%69.4%
Operating margin16.0%16.2%14.4%3.9%
Net margin15.9%17.8%16.7%4.9%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings15.814.514.913.215.065.4-91.8-12.8-36.9-190.8
Price to sales2.22.52.72.93.33.43.95.56.212.9

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 27 Jun 2025.

FY2025FY2024
Paid in the year30.0010.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.